iSpecimen Inc. Proceeds from Stock Options Exercised
iSpecimen Inc. (ISPC) reported Proceeds from Stock Options Exercised of $0 for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-18.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2026-05-18
- iSpecimen Inc. proceeds from stock options exercised for the quarter ending 2026-03-31 was $0.00.
- iSpecimen Inc. proceeds from stock options exercised for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- iSpecimen Inc. proceeds from stock options exercised for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- iSpecimen Inc. proceeds from stock options exercised for the quarter ending 2023-06-30 was $3.15K, a 72.58% increase year-over-year.
- iSpecimen Inc. proceeds from stock options exercised for fiscal 2023 was $70.89K, a 9.86% decline from fiscal 2022.
- iSpecimen Inc. proceeds from stock options exercised for fiscal 2022 was $78.64K, a 34.09% increase from fiscal 2021.
- iSpecimen Inc. proceeds from stock options exercised for fiscal 2021 was $58.65K.
- iSpecimen Inc. proceeds from stock options exercised for fiscal 2020 was $0.00.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2026-03-31 | $0.00 10-Q · filed 2026-05-18 | |||
| 2025-12-31 | $0.00 10-Q · filed 2026-05-18 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-14 | $0.00 derived: sum of 2 quarters · filed 2025-04-14 | $3.15K derived: sum of 3 quarters · filed 2025-04-14 | $70.89K 10-K · filed 2025-04-14 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $3.15K derived: sum of 2 quarters · filed 2024-11-07 | $70.89K 10-Q · filed 2024-11-07 | $71.14K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $3.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $70.89K 10-Q · filed 2024-08-06 | $71.14K derived: sum of 3 quarters · filed 2024-08-06 | $72.43K derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $67.74K 10-Q · filed 2024-05-07 | $67.99K derived: sum of 2 quarters · filed 2024-05-07 | $69.27K derived: sum of 3 quarters · filed 2024-05-07 | $71.10K derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $254.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $1.54K derived: sum of 2 quarters · filed 2024-03-13 | $3.36K derived: sum of 3 quarters · filed 2024-03-13 | $78.64K 10-K · filed 2024-03-13 |
| 2022-09-30 | $1.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $3.11K derived: sum of 2 quarters · filed 2023-11-02 | $78.39K 10-Q · filed 2023-11-02 | $92.64K derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $1.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $77.10K 10-Q · filed 2023-08-02 | $91.36K derived: sum of 3 quarters · filed 2023-08-02 | $96.12K derived: sum of 4 quarters · filed 2023-08-02 |
| 2022-03-31 | $75.28K 10-Q · filed 2023-05-04 | $89.53K derived: sum of 2 quarters · filed 2023-05-04 | $94.29K derived: sum of 3 quarters · filed 2023-05-04 | |
| 2021-12-31 | $14.25K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-30 | $19.02K derived: sum of 2 quarters · filed 2023-03-30 | $58.65K 10-K/A · filed 2023-03-30 | |
| 2021-09-30 | $4.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $44.39K 10-Q · filed 2022-11-08 | ||
| 2021-06-30 | $39.63K 10-Q · filed 2022-08-04 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $0.00 derived: sum of 2 quarters · filed 2022-03-22 | $0.00 10-K · filed 2022-03-22 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $0.00 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |